You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
Audience
- Remove Advertisers filter Advertisers (3)
- Consumers (8) Apply Consumers filter
- Health professionals (7) Apply Health professionals filter
- Remove Manufacturers filter Manufacturers (7)
- Remove Sponsors filter Sponsors (10)
Filters applied:
- (-) Remove Sponsors filter Sponsors
- (-) Remove Advertisers filter Advertisers
- (-) Remove Manufacturers filter Manufacturers
27 June 2022
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
20 December 2021
Frequently asked questions for new sponsors in relation to the supply of disinfectant products.
2 August 2021
Disinfectants and related products: Regulation of borderline antiviral claims, including in relation to COVID-19
26 August 2020
There is significant interest from potential sponsors and manufacturers to understand how disinfectants are regulated and how to supply them
26 August 2020
Guidance for new sponsors in relation to the supply, import, and export of disinfectant products.
8 May 2020
Consumers should be alert to misleading claims made online about Miracle Mineral Solution (MMS). The TGA has not approved MMS for use to treat, cure, prevent or alleviate any disease or condition.
7 May 2020
Information for hand sanitiser manufacturers, suppliers and advertisers about meeting their regulatory obligations.
7 May 2020
For sponsors and manufacturers wishing to make label claims of efficacy against COVID-19 for products that are either hard surface disinfectants or disinfectants that are medical devices
28 April 2020
Advice for faecal microbiota transplant (FMT) providers on safety protections related to COVID-19.
31 March 2020
Clarification about the clinical trial process as it relates to COVID-19
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
